Pivotal Life Sciences logo

Pivotal Life Sciences

North America, California, United States, San Francisco

Description

Pivotal Life Sciences focuses on building data platforms and applications for life sciences investments.

Investor Profile

Pivotal Life Sciences has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (67%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (67%)
  • China (33%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Life Science
  • Pharmaceutical
  • Primary And Urgent Care
  • Professional Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pivotal Life Sciences frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
TCG Crossover
North America, California, United States, Palo Alto
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Abrdn
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Pivotal Life Sciences?

Engrail Therapeutics

San Diego, California, United States

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Health CareLife ScienceMedicalPharmaceutical
Series BMar 19, 2024
Amount Raised: $157,000,000
Gracell Biotechnologies

Suzhou, Jiangsu, China

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 7, 2023
Amount Raised: $100,000,000
Aptihealth

Troy, New York, United States

Aptihealth specializes in behavioral health, health plans, primary care, therapy, direct messaging, and medication management services.

Health CareMedicalPrimary and Urgent CareProfessional Services
Series BNov 17, 2021
Amount Raised: $50,000,000